2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
  • United States
  • United Kingdom
  • Canada
  • Israel
  • Germany
  • France
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotechnology
  • Precision Medicine
  • Diagnostics
  • Medical Devices
  • Digital Health
About
BCRF Ventures is a New York-based venture capital firm focused on accelerating breast cancer innovations from research to clinical impact. Their focus spans breast cancer therapeutics, precision medicine, diagnostics, and digital health across the United States, United Kingdom, Canada, Israel, Germany, and France. The firm supports oncology founders from seed through Series B stages.
Min check size
$500K
Max check size
$5M
Fund size
NPS

Investment Thesis

BCRF Ventures is a seed to Series B stage venture capital firm deploying capital across breast cancer therapeutics, precision medicine, diagnostics, biotech, medical devices, digital health, and oncology sectors. They invest in early-stage companies commercializing breast cancer innovations emerging from Breast Cancer Research Foundation-funded research and broader oncology innovation. The firm differentiates itself as the venture arm of the Breast Cancer Research Foundation (largest private funder of breast cancer research globally), providing scientific expertise, clinical networks, and mission-aligned capital to accelerate breast cancer breakthroughs.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Launched in 2024 as the venture arm of the Breast Cancer Research Foundation (largest private funder of breast cancer research globally). Led by Dr. Dorraya El-Ashry (Chief Scientific Officer of BCRF, oversees investment strategy). Team combines BCRF's scientific expertise with venture investing capabilities. Focused on accelerating breast cancer innovations from research to clinical impact through direct investments in oncology-focused biotech, precision medicine, and digital health startups. Backed by BCRF's donor network and mission-aligned institutional partners.

BCRF Ventures Contacts Information

Primary contact

Secondary contact

Team

Dr. Dorraya El-Ashry - Chief Scientific Officer of BCRF (oversees investment strategy)

Portfolio

Clairity

Inc.

Fund number
Year Founded
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp